AF
FBLG icon

Allworth Financial’s FibroBiologics FBLG Stock Holding History

Allworth Financial’s Portfolio FBLG Stock Details FBLG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18 Hold
13
– – ﹤0.01% 5139
2025
Q4 		$59 Hold
13
– – ﹤0.01% 4830
2025
Q3 		$143 Hold
13
– – ﹤0.01% 4640
2025
Q2 		$163 Hold
13
– – ﹤0.01% 4344
2025
Q1 		$337 Hold
13
– – ﹤0.01% 3774
2024
Q4 		$441 Hold
13
– – ﹤0.01% 3636
2024
Q3 		$806 Hold
13
– – ﹤0.01% 3296
2024
Q2 		$1.17K Hold
13
– – ﹤0.01% 3113
2024
Q1 		$2.82K Buy
+13
New +$3.13K ﹤0.01% 2675

Other funds holding FBLG

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FEG
Fund Evaluation Group Cincinnati, Ohio $3.25B AUM 14.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFP
Cascade Financial Partners San Diego, California $970M AUM 19.9% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
VGA
Vanguard Global Advisers Malvern, Pennsylvania $187B AUM

Allworth Financial's FBLG Position: Q1 2026 in Review

Allworth Financial held its FibroBiologics (FBLG) position steady in Q1 2026 at 13 shares worth $18. The position accounts for ﹤0.01% of the portfolio, ranked #5139.

Allworth Financial first reported a position in FBLG in Q1 2024 and has held it in 9 quarters since. The position peaked at $2.82K in Q1 2024. 17 funds tracked by Wall St. Rank hold FBLG as of Q1 2026.

  • Allworth Financial held 13 shares of FibroBiologics worth $18 as of Q1 2026.
  • Allworth Financial left its FibroBiologics share count unchanged in Q1 2026.
  • FibroBiologics made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #5139 holding.
  • Allworth Financial first reported a position in FibroBiologics in Q1 2024 and has held it in 9 quarters since.
  • Allworth Financial's FibroBiologics position peaked at $2.82K in Q1 2024.
  • 17 funds tracked by Wall St. Rank held FibroBiologics as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.